CRYSTAL GREEN: Open Payments
NPI 1306472311 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,450 in 81 payments from 18 companies in 2025. Trend: 2023 $702 · 2024 $945 · 2025 $1,450
Food & beverage: $1,450
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $318 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $168 |
| Ardelyx, Inc. | 9 | $149 |
| Aimmune Therapeutics, Inc. | 8 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $140 |
| GENZYME CORPORATION | 8 | $135 |
| Madrigal Pharmaceuticals | 3 | $72 |
| Gilead Sciences, Inc. | 2 | $56 |
| Intercept Pharmaceuticals, Inc. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 5 | $42 |
Products named: XIFAXAN, DUPIXENT, IBSRELA, ZENPEP, RINVOQ, ENTYVIO, REZDIFFRA, CREON.
Industry payments across NC — which companies pay providers there.
